Bahrain approves Russian Sputnik V Covid-19 vaccine - RDIF

Interfax, 10.02.2021

MOSCOW. Feb 10 (Interfax) - The Kingdom of Bahrain has approved the Russian coronavirus vaccine Sputnik V, the Russian Direct Investment Fund (RDIF) said in a statement on Wednesday.

"The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain," it said.

The vaccine was approved under the emergency use authorization procedure without additional clinical trials in the country, RDIF said.

Bahrain has become the 24th country to authorize the Sputnik V vaccine, which was earlier approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, the Palestinian territories, Venezuela, Paraguay, Turkmenistan, Hungary, the United Arab Emirates, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (an entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, and Mongolia.

RDIFsaid earlier that Sputnik V will have authorization in 25 countries this week.